Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 511
Filtrar
2.
Br J Surg ; 101(9): 1143-52, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24947893

RESUMO

BACKGROUND: The node classification outlined in the seventh edition of the TNM classification is based solely on the number of metastasized lymph nodes. This study examined the prognostic value of apical lymph node (ALN) metastasis and the additional value of incorporating ALN status into a risk model based on the seventh edition. METHODS: This was a cohort study of patients with stage III colonic cancer who underwent tumour resection with dissection of regional (including apical) lymph nodes at 71 hospitals across Japan between 2000 and 2002. The main exposure was pathologically confirmed ALN metastasis, and the primary endpoint was cancer-specific death. RESULTS: ALN metastasis was present in 113 (8·3 per cent) of 1355 patients. During 5356 patient-years of follow-up (median 5·0 years), 221 instances (16·3 per cent) of cancer-specific death were observed. After adjustment for tumour and node classification (as described in the seventh edition of the TNM classification) and other prognostic factors, ALN metastasis was found to be independently associated with cancer-specific death (hazard ratio 2·29, 95 per cent confidence interval (c.i.) 1·49 to 3·52). Incorporation of ALN metastasis into the prognostic model based on the seventh edition of the TNM classification significantly improved discriminative performance for cancer-specific death (difference in concordance index 0·0146, 95 per cent c.i. 0·0030 to 0·0262) and risk reclassification for cancer-specific death at 5 years (category-free net reclassification improvement 19·4 (95 per cent c.i. 5·0 to 33·4) per cent). CONCLUSION: Assessment of ALN metastasis provided independent prognostic information beyond that achievable with the seventh edition of the TNM classification in patients with stage III colonic cancer.


Assuntos
Neoplasias do Colo/mortalidade , Metástase Linfática , Estadiamento de Neoplasias , Idoso , Estudos de Coortes , Neoplasias do Colo/patologia , Feminino , Humanos , Japão/epidemiologia , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Prognóstico , Medição de Risco
3.
Colorectal Dis ; 15(2): 244-51, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22776077

RESUMO

AIM: The aim of this prospective study was to clarify the frequency of male sexual dysfunction after laparoscopic total mesorectal excision (LTME) and to examine the relationship between pelvic autonomic nerve (PAN) preservation status and functional outcomes. METHOD: Candidates for LTME were included in this study. PAN preservation status after LTME was examined in detail by video review. Patients completed a functional questionnaire (the International Index of Erectile Function) before and 3, 6 and 12 months after the operation. RESULTS: Twenty-six patients who underwent LTME were assessable. Detailed video reviews identified inadvertent PAN damage during surgery. PAN injury was observed in 11 cases (41%), including eight cases (32%) of inadvertent PAN damage (incomplete preservation group). There was a trend toward increasing inadvertent PAN injury rate in patients with high body mass index and large tumours. The results from all patients who underwent LTME showed no deterioration in total International Index of Erectile Function or its domain scores 12 months after surgery. In the incomplete preservation group, these scores temporarily decreased (3 and 6 months after surgery), but such deterioration was not observed in the complete preservation group. Most of the 12 patients with potentially active erectile function before the operation recovered this function, and only one patient (7%) with PAN injury was still judged as inactive 12 months after surgery. CONCLUSION: The proportion of patients with sexual dysfunction after LTME is low. With the enhanced visibility of the laparoscope, inadvertent PAN injury was detected in a significant number of cases and associated with transient deterioration of sexual function.


Assuntos
Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Disfunção Erétil/etiologia , Pelve/inervação , Traumatismos dos Nervos Periféricos/etiologia , Neoplasias Retais/cirurgia , Reto/cirurgia , Adulto , Idoso , Análise de Variância , Sistema Nervoso Autônomo/fisiopatologia , Procedimentos Cirúrgicos do Sistema Digestório/métodos , Seguimentos , Humanos , Entrevistas como Assunto , Laparoscopia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Pelve/patologia , Complicações Pós-Operatórias/etiologia , Estudos Prospectivos , Neoplasias Retais/fisiopatologia , Inquéritos e Questionários , Gravação em Vídeo
4.
J Phys Condens Matter ; 23(22): 225404, 2011 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-21593552

RESUMO

The characteristics of cation diffusion with many-body effects are discussed using Ag ß-alumina as an example of a superionic conductor. Polarized Raman spectra of Ag ß-alumina have been measured at room temperature. The interatomic potentials were determined by a non-linear least square fitting between the phonon eigenvalues from the Raman observations and a dynamical matrix calculation based on a rigid-ion model. The obtained potential parameters for the model crystal of Ag ß-alumina successfully reproduce the macroscopic properties with respect to the heat capacity, isothermal compressibility and self-diffusion constant. A molecular dynamics (MD) calculation has been carried out using the model crystal of Ag ß-alumina to understand the many-body effects for the fast ionic diffusion. It was found that the Ag-Ag repulsion by excess Ag defects significantly reduced the cost of the energy difference of the occupancy between the stable and metastable sites. It is possible for the system to take various configurations of the mobile ions through defects easily, and then the fast ionic diffusion will appear. On the other hand, the Ag-Ag repulsion changes the dynamics of the Ag ions from a random hopping to a cooperative motion. In the cooperative motion, the ionic transport becomes difficult due to the additional energy required for the structural relaxation of the surrounding Ag ions. We propose a new insight into the superionic conduction, that is, the activation energy for the ionic transport is composed of two kinds of elements: a 'static' activation energy and a 'dynamic' one. The static activation energy is the cost of the averaged energy difference in the various structural configurations in the equilibrium state. The dynamic activation energy is the additional energy required for the structural relaxation induced by the jump process.

5.
J Dent Res ; 89(11): 1309-14, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20739703

RESUMO

We have reported that mustard oil application to the rat dental pulp induces neuronal activation in the thalamus. To address the mechanisms involved in the thalamic changes, we performed neuronal responsiveness recording, immunohistochemistry, and molecular biological analysis. After mustard oil application, neuronal responsiveness was increased in the mediodorsal nucleus. When MK801 (an N-methyl-D-aspartate receptor antagonist) was applied to the mediodorsal nucleus, the enhanced responsiveness was decreased. N-methyl-D-aspartate receptor 2D, glial fibrillary acidic protein, and antigen-presenting cell-related gene mRNAs in the contralateral thalamus were up-regulated at 10 minutes after mustard oil application, but were down-regulated within 10 minutes after the antagonist application. OX6-expressing microglia and glial fibrillary acidic protein-expressing astrocytes did not increase until 60 minutes after mustard oil application. These results suggested that the thalamic neurons play some roles in regulating the glial cell activation in the mediodorsal nucleus via N-methyl-D-aspartate receptor 2D during pulp inflammation-induced central sensitization.


Assuntos
Polpa Dentária/efeitos dos fármacos , Mostardeira/efeitos adversos , Óleos de Plantas/efeitos adversos , Tálamo/imunologia , Animais , Células Apresentadoras de Antígenos/imunologia , Astrócitos/imunologia , Astrócitos/fisiologia , Polpa Dentária/imunologia , Polpa Dentária/inervação , Maleato de Dizocilpina/farmacologia , Estimulação Elétrica , Antagonistas de Aminoácidos Excitatórios/farmacologia , Proteína Glial Fibrilar Ácida/análise , Imuno-Histoquímica , Masculino , Núcleo Mediodorsal do Tálamo/efeitos dos fármacos , Núcleo Mediodorsal do Tálamo/fisiologia , Microglia/imunologia , Microglia/fisiologia , Dente Molar/efeitos dos fármacos , Dente Molar/imunologia , Dente Molar/inervação , Biologia Molecular , Vias Neurais/imunologia , Neuroglia/imunologia , Neuroglia/fisiologia , Neuroimunomodulação/imunologia , Neuroimunomodulação/fisiologia , Neurônios/imunologia , Neurônios/fisiologia , Pulpite/induzido quimicamente , Pulpite/imunologia , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/análise , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Tálamo/efeitos dos fármacos
6.
J Int Med Res ; 36(1): 106-14, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18230274

RESUMO

This prospective, open-label, multicentre study examined the efficacy and safety of rapidly (overnight) or slowly (after 2 weeks of concomitant usage) switching patients with Parkinson's disease (PD) from conventional ergot dopamine agonists (DAs) to the non-ergot DA, pramipexole. Fifty-nine early-to-advanced PD patients with motor symptoms that were inadequately controlled by ergot DAs were enrolled. Patients were switched from ergot derivatives to pramipexole and evaluated every 2 weeks for 12 weeks by Hoehn and Yahr staging, Unified Parkinson's Disease Rating Scale (UPDRS) and a modified Epworth Sleepiness Scale (mESS). The UPDRS III subscores and total UPDRS scores significantly improved, independent of switching method. Adverse events, all of which were mild, occurred in 29.2% of patients. No sudden onset of excessive daytime sleepiness or significant worsening in mESS was seen. Switching patients with PD from ergot DA to pramipexole, using either a slow or rapid switching method, appeared to be well tolerated and effective, although further dose adjustment may be necessary in some patients after the switch.


Assuntos
Antiparkinsonianos/uso terapêutico , Benzotiazóis/uso terapêutico , Agonistas de Dopamina/uso terapêutico , Ergolinas/uso terapêutico , Doença de Parkinson/tratamento farmacológico , Adulto , Antiparkinsonianos/administração & dosagem , Benzotiazóis/administração & dosagem , Bromocriptina/administração & dosagem , Bromocriptina/uso terapêutico , Cabergolina , Agonistas de Dopamina/administração & dosagem , Esquema de Medicação , Ergolinas/administração & dosagem , Feminino , Humanos , Doença de Parkinson/diagnóstico , Doença de Parkinson/fisiopatologia , Pergolida/administração & dosagem , Pergolida/uso terapêutico , Pramipexol , Estudos Prospectivos , Índice de Gravidade de Doença , Resultado do Tratamento
7.
Kyobu Geka ; 60(12): 1043-8; discussion 1048-50, 2007 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-18018643

RESUMO

We report 3 cases of left ventriculoplasty (LVP). They were chosen according to classification of the preoperative left venticle (LV) shape; an apex type and anteroseptal type. We think that an apex type has an indication for a Dor operation and the treatment of an anteroseptal type should be chosen between the following 2 methods. One is an overlapping method. It has the advantage of having to use no intracardiac patch which would remain akinetic area. It is therefore suitable for relatively small LV aneurysms without involvement of the proximal diagonal branches. However, it has the disadvantage of having to cut some distal diagonal branches in order to perform the volume reduction. The other method is a septal anterior ventricular exclusion (SAVE) operation. It is suitable for larger LV aneurysms which involve the proximal diagonal branches due to its advantage of being able to perform the LVP without cutting the diagonal branches. However, it has the disadvantage of leaving an akinetic area that corresponds to the intracardiac patch. We believe that choice of the LVP method according to the preoperative LV shape will bring about a better postoperative LV function and shape.


Assuntos
Procedimentos Cirúrgicos Cardiovasculares/métodos , Aneurisma Cardíaco/complicações , Aneurisma Cardíaco/cirurgia , Isquemia Miocárdica/etiologia , Isquemia Miocárdica/cirurgia , Idoso , Ventrículos do Coração/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
8.
Spectrochim Acta A Mol Biomol Spectrosc ; 65(5): 1234-40, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16822712

RESUMO

The polymer electrolytes composed of poly(vinyl acetate) (PVAc) with various stoichiometric ratios of lithium perchlorate (LiClO(4)) salt have been prepared by solution casting method. The techniques Fourier transform infra-red (FTIR) and Laser Raman spectroscopy have been used to monitor polymer-salt complex formation, ion-ion and ion-polymer interactions as a function of salt concentration. Significant changes in both Laser Raman and FTIR spectra are observed which reveals an interaction between ester oxygens with lithium cation coordination. These results strongly suggest the interaction of lithium cation and network polymer chains. When the salt content is increased, the intensity of the internal Raman modes of the ClO(4)(-) increases. The ClO(4)(-) stretching mode observed at 934 cm(-1) in Laser Raman shows some additional shoulder peaks with increase in salt concentration. This reveals the presence of free anions, ion contact pairs and higher order ionic clusters. From the FTIR and Laser Raman results the transport mechanism of ions in PVAc:LiClO(4) polymer electrolytes has been discussed.


Assuntos
Compostos de Lítio/química , Lítio/metabolismo , Percloratos/química , Polivinil/química , Análise Espectral Raman/métodos , Eletrólitos/química , Transporte de Íons/fisiologia , Compostos de Lítio/metabolismo , Percloratos/metabolismo , Polímeros/química , Polivinil/metabolismo , Espectroscopia de Infravermelho com Transformada de Fourier
9.
Diabetologia ; 49(5): 962-8, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16525841

RESUMO

AIMS/HYPOTHESIS: G protein-coupled receptor 40 (GPR40) is abundantly expressed in pancreatic beta cells in rodents, where it facilitates glucose-induced insulin secretion in response to mid- to long-chain fatty acids in vitro. However, GPR40 gene expression in humans has not been fully investigated, and little is known about the physiological and pathophysiological roles of GPR40 in humans. The aim of this study, therefore, was to examine GPR40 expression and its clinical implications in humans. METHODS: GPR40 mRNA expression in the human pancreas, pancreatic islets and islet cell tumours was analysed using TaqMan PCR. RESULTS: GPR40 mRNA was detected in all human pancreases collected intraoperatively. It was enriched approximately 20-fold in isolated islets freshly prepared from the pancreases of the same individuals. The estimated mRNA copy number for the GPR40 gene in pancreatic islets was comparable to those for genes encoding sulfonylurea receptor 1, glucagon-like peptide 1 receptor and somatostatin receptors, all of which are known to be expressed abundantly in the human pancreatic islet. A large amount of GPR40 mRNA was detected in insulinoma tissues, whereas mRNA expression was undetectable in glucagonoma or gastrinoma. The GPR40 mRNA level in the pancreas correlated with the insulinogenic index, which reflects beta cell function (r=0.82, p=0.044), but not with glucose levels during the OGTT, the insulin area under the OGTT curve or the index for the homeostasis model assessment of insulin resistance (HOMA-IR). CONCLUSIONS/INTERPRETATION: The present study provides evidence for GPR40 gene expression in pancreatic beta cells and implicates GPR40 in insulin secretion in humans.


Assuntos
Insulina/metabolismo , Insulinoma/genética , Neoplasias Pancreáticas/genética , Receptores Acoplados a Proteínas G/genética , Adulto , Idoso , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Secreção de Insulina , Ilhotas Pancreáticas/metabolismo , Masculino , Pessoa de Meia-Idade , Receptores Acoplados a Proteínas G/fisiologia
10.
Eur J Cancer ; 39(15): 2239-46, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14522385

RESUMO

Peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimerises with retinoid X receptor alpha (RXRalpha) and is thought to be a novel therapeutic target for human malignancies. We evaluated the ability of troglitazone (TRO) alone or in combination with 9-cis retinoic acid (9CRA), ligands of PPARgamma and RXRalpha, respectively, to inhibit the growth of oesophageal squamous cell carcinoma (OSCC). All 10 tested OSCC cell lines of a KYSE series expressed PPARgamma and RXRalpha at both the mRNA and protein levels. In four tested cell lines, TRO inhibited growth, and a synergistic effect was observed with simultaneous 9CRA application. In KYSE 270 cells, a luciferase reporter assay showed that the simultaneous application of TRO and 9CRA to the cells increased the relative luciferase activity approximately 20-fold compared with the controls without TRO or 9CRA application. In this cell line, flow cytometry demonstrated that combined treatment with TRO and 9CRA greatly increased the sub-G1 phase, and Hoechst 33342/propidium iodide (PI) staining showed that apoptotic cell death was mainly induced through ligand treatment. In addition, implanted tumours in nude mice showed significant inhibition of tumour growth when treated with TRO. These results suggest that the PPARgamma/RXRalpha heterodimer may be a new therapeutic target for OSCC.


Assuntos
Antineoplásicos/uso terapêutico , Carcinoma de Células Escamosas/tratamento farmacológico , Cromanos/uso terapêutico , Neoplasias Esofágicas/tratamento farmacológico , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores do Ácido Retinoico/metabolismo , Tiazolidinedionas/uso terapêutico , Fatores de Transcrição/metabolismo , Alitretinoína , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Western Blotting , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Caspases/metabolismo , Divisão Celular/efeitos dos fármacos , Cromanos/administração & dosagem , Avaliação de Medicamentos , Neoplasias Esofágicas/metabolismo , Neoplasias Esofágicas/patologia , Humanos , RNA Mensageiro/metabolismo , Receptores X de Retinoides , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tiazolidinedionas/administração & dosagem , Tretinoína/administração & dosagem , Troglitazona , Células Tumorais Cultivadas
11.
Hematology ; 7(2): 109-12, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12186701

RESUMO

A 54-year-old woman developed polymyositis 6 months after allogeneic bone marrow transplantation (BMT) for acute myelogenous leukemia transformed from myelodysplasia. At the onset of myositis, the patient had oral dryness, and the histology of oral mucosa was compatible with chronic graft-versus-host disease (GVHD). Muscle biopsy revealed focal muscle necrosis with massive lymphocytic infiltration. She was diagnosed with polymyositis, and the dose of cyclosporine was increased. Three months later, a complete resolution of myositis had been obtained, and the cyclosporine was tapered off. However, 51 months after the first episode of myositis, she again noted severe myalgia and was diagnosed with a recurrence of polymyositis based on high serum creatinine kinase (CK) and the findings of magnetic resonance imaging (MRI). At that time, chronic GVHD in other organs was not present. She achieved a second remission of polymyositis with cyclosporine, and has remained in remission for 4 years. The pathogenesis of myositis can be attributed to the immunologic imbalance characteristic of the post-allogeneic BMT setting.


Assuntos
Transplante de Medula Óssea/efeitos adversos , Miosite/etiologia , Defeitos do Tubo Neural/terapia , Ciclosporina/administração & dosagem , Feminino , Humanos , Sistema Imunitário/patologia , Leucemia Mieloide Aguda/etiologia , Leucemia Mieloide Aguda/terapia , Pessoa de Meia-Idade , Miosite/diagnóstico , Miosite/tratamento farmacológico , Defeitos do Tubo Neural/patologia , Recidiva , Transplante Homólogo/efeitos adversos
12.
Int J Cancer ; 94(3): 370-6, 2001 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-11745416

RESUMO

Peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed largely in adipose tissues and plays an important role in adipocyte differentiation. Several studies have recently shown that ligands of PPARgamma could lead to growth inhibition in some malignancies. In our study, we focused on pancreatic cancers, because the prognosis of advanced pancreatic cancer has not significantly improved due to its resistance to various chemotherapeutic regimens, so that a novel strategy should be required. We show here that PPARgamma is expressed in 5 pancreatic cancer cell lines detected in both mRNA and protein level as well as in human primary and metastatic pancreatic carcinomas examined by immunohistochemical studies. A specific ligand of PPARgamma, troglitazone, led to G1 accumulation with the increase in p27(Kip1), but not p21(Waf1/Cip1) and inhibited cellular proliferation in a pancreatic cancer cell line, Panc-1. The overexpression of PPARgamma in a pancreatic cancer cell line, KMP-3, caused lipid accumulation, which suggested cell growth in some cancers might be inhibited, at least in part, through terminal differentiation in the adipogenic lineage. In addition, implanted Panc-1 tumors in nude mice showed significant inhibition of tumor growth, when treated with pioglitazone, another specific ligand of PPARgamma. Our results suggest that ligands of PPARgamma may be a novel therapeutic agent for the treatment of pancreatic carcinomas.


Assuntos
Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/terapia , Receptores Citoplasmáticos e Nucleares/metabolismo , Tiazolidinedionas , Fatores de Transcrição/metabolismo , Adipócitos/citologia , Animais , Antineoplásicos/farmacologia , Ciclo Celular , Proteínas de Ciclo Celular/biossíntese , Diferenciação Celular , Divisão Celular , Cromanos/farmacologia , Inibidor de Quinase Dependente de Ciclina p21 , Inibidor de Quinase Dependente de Ciclina p27 , Ciclinas/biossíntese , DNA Complementar/metabolismo , Relação Dose-Resposta a Droga , Citometria de Fluxo , Fase G1/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Cinética , Ligantes , Luciferases/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Fenótipo , Prognóstico , RNA/metabolismo , RNA Mensageiro/metabolismo , Tiazóis/farmacologia , Fatores de Tempo , Transcrição Gênica , Ativação Transcricional , Troglitazona , Células Tumorais Cultivadas , Proteínas Supressoras de Tumor/biossíntese
14.
Hinyokika Kiyo ; 47(8): 595-8, 2001 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-11579604

RESUMO

A 78-year-old female suffering from a cerebral infarction and subdural hematoma was referred to us due to a hard mass in the anterior vaginal wall which was disclosed during gynecological examination. An abdominal X-ray, computed tomography (CT) and magnetic resonance imaging (MRI) showed that a large spindle-shaped stone, 60 x 42 mm in size, was impacting the urethra. It was impossible to catheterize the urethra. The stone gradually projected through the external urethral meatus and was removed by grasping and drawing with forceps. Another 83-year-old female with senile dementia was referred to us because of macrohematuria. An abdominal X-ray and CT showed the presence of two oval bladder stones, 32 x 24 mm and 30 x 21 mm in size. During a follow-up, one of the stones projected partially through the external urethral meatus and was removed by drawing with forceps. After a week, the other stone impacted the urethra and was removed in the same way. Both women were frail, bedridden institutionalized elderly with severe dementia, and their urination had been managed with diapers for years. As the proportion of elderly people in Japan rapidly increases, female urethral stones migrating from the urinary bladder, once very rare, may increase in number, to which we must pay attention.


Assuntos
Doenças Uretrais/etiologia , Cálculos Urinários/etiologia , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos
19.
Exp Cell Res ; 269(1): 73-87, 2001 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-11525641

RESUMO

Migration of endothelial cells induced by vascular endothelial growth factor (VEGF) is a critical step in angiogenesis. Stimulation of motility by growth factors such as VEGF requires interaction with the signal transduction pathways activated by the extracellular matrix (ECM). Here we demonstrate that the Rac GTPase is the critical intersection activated by type 1 collagen ECM and VEGF during stimulation of endothelial cell motility. To analyze the role of the Rho family GTPases in VEGF-stimulated endothelial cell chemotaxis and ECM-stimulated haptotaxis, we transduced the respective fusion proteins in human foreskin dermal endothelial cells using a Tat peptide from the human immunodeficiency virus Tat protein. VEGF signaling required Rac activation during chemotaxis, and Rac and Cdc42 were activated during haptotaxis on type I collagen. Similar to VEGF, Rac activation induced an increase in endothelial cell stress fiber and focal adhesion. Surprisingly, Rho activation was not present in collagen-induced haptotaxis or stimulation of chemotaxis by VEGF, although Rho induced stress fibers and focal adhesions similar to Rac activation. The result of constitutive Rho activation was an inhibition of haptotaxis. Thus, Rac is required and sufficient for the activation of endothelial cell haptotaxis and VEGF-stimulated chemotaxis.


Assuntos
Movimento Celular/fisiologia , Fatores de Crescimento Endotelial/metabolismo , Endotélio Vascular/enzimologia , Linfocinas/metabolismo , Neovascularização Fisiológica/fisiologia , Proteínas rho de Ligação ao GTP/metabolismo , Actinas/efeitos dos fármacos , Actinas/metabolismo , Antimaláricos/farmacologia , Movimento Celular/efeitos dos fármacos , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/metabolismo , Quimiotaxia/efeitos dos fármacos , Quimiotaxia/fisiologia , Cloroquina/farmacologia , Colágeno/efeitos dos fármacos , Colágeno/metabolismo , Citoesqueleto/efeitos dos fármacos , Citoesqueleto/metabolismo , Fatores de Crescimento Endotelial/farmacologia , Endotélio Vascular/efeitos dos fármacos , Matriz Extracelular/efeitos dos fármacos , Matriz Extracelular/metabolismo , Imunofluorescência , Produtos do Gene tat/genética , Humanos , Linfocinas/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Proteínas Recombinantes de Fusão/genética , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Fator A de Crescimento do Endotélio Vascular , Fatores de Crescimento do Endotélio Vascular , Vinculina/efeitos dos fármacos , Vinculina/metabolismo , Proteína cdc42 de Ligação ao GTP/metabolismo , Proteínas rac de Ligação ao GTP/efeitos dos fármacos , Proteínas rac de Ligação ao GTP/metabolismo , Proteínas rho de Ligação ao GTP/efeitos dos fármacos
20.
Cancer Gene Ther ; 8(7): 483-90, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11498769

RESUMO

One of the main objectives of cancer immunotherapy is the activation and increase in number of antitumor effector cells. Recently, genetically modified tumor cell vaccines have been proposed for elicitation of antitumor effector cells. Native alpha antigen (alpha Ag) (also known as MPT59 and antigen 85B) of mycobacteria, which cross-reacts among mycobacteria species, may play an important biological role in host-pathogen interaction because it elicits various helper T-cell type 1 immune responses. To assess the induction of antitumor immune responses by alpha Ag, mouse tumor cell lines transfected with cDNA of alpha Ag from Mycobacterium kansasii were established, and the possibility of producing a tumor cell vaccine for induction of antitumor effects was explored. Transfection of tumor cell lines with an alpha Ag gene lead to primary tumor rejection and the establishment of protective immunity to nontransfected original tumor cell lines in Mycobacterium bovis bacillus Calmette-Gurin (BCG)-primed and unprimed mice. Mice immunized with tumor cell lines transfected with the alpha Ag gene showed delayed-type hypersensitivity responses in vivo and proliferative responses together with induction of interferon-gamma of spleen cells against nontransfected wild-type tumor cell lines in in vitro experiments. Moreover, immunization of mice with alpha Ag-expressing tumor cells elicited tumor-specific and cytotoxic T lymphocyte (CTL) epitope peptide-specific CD8+ CTLs. The results of this study provided evidence of the potential usefulness of alpha Ag in tumor cell vaccines.


Assuntos
Antígenos de Bactérias/genética , Vacinas Anticâncer , DNA/genética , Terapia Genética/métodos , Neoplasias da Bexiga Urinária/imunologia , Neoplasias da Bexiga Urinária/terapia , Animais , Interferon gama/biossíntese , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Mycobacterium bovis/imunologia , Mycobacterium bovis/metabolismo , Biossíntese Peptídica , Baço/citologia , Linfócitos T Citotóxicos/metabolismo , Fatores de Tempo , Transfecção , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...